Rubicon Research Limited
Premji Invest bought 301,202 shares of Rubicon Research Limited for ₹50.00 Cr at ₹1660.00 apiece in a block deal.
A pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated drug formulations across multiple therapeutic areas. Incorporated in 1999, the company specializes in creating specialized formulations that address specific medical needs in the Indian healthcare market. Its integrated operations span research and development, manufacturing of quality pharmaceuticals, and distribution. The company distinguishes itself through its focus on bringing innovative, differentiated solutions to patients and healthcare providers.
Family office of Wipro founder Azim Premji, founded in 2006. Manages around USD 15 bn (~Rs 1,25,000 cr) across listed equities, growth PE, venture and buyouts, with 119+ portfolio companies. Backed Akasa Air, FirstCry, Lenskart and others. The original Indian billionaire family office, deploying ~USD 10 bn of Premji's personal capital across long-term plays in financial services, tech, consumer, industrials and healthcare.
